OnKure Inc.

---

OnKure hires chief medical officer as drug trials loom

 February 20, 2024 2:50:02 pm

---

OnKure’s lead cancer-drug candidate clears FDA hurdle

 January 4, 2024 6:33:16 pm

---

OnKure closes Series C at $54M

 May 23, 2023 6:12:29 am

---

OnKure aims for $60M in new funding round

 April 3, 2023 3:24:52 pm

---

OnKure Therapeutics hires clinical development leader

 December 12, 2022 1:50:39 pm

---

OnKure Therapeutics appoints new vice president

 June 27, 2022 2:58:36 pm

---

OnKure doses first study patient with skin cancer drug combination

 June 7, 2022 6:59:29 am

---

OnKure expands with new laboratory for cancer-drug research

 April 25, 2022 9:48:05 pm

---

OnKure hires former Pfizer, Array exec

 November 9, 2021 2:06:26 pm

---

Oncology firm OnKure raises $55M

 March 4, 2021 8:49:52 pm

Next Page »